Similar articles

• Operative risk in coronary revascularization of patients with ventricular dysfunction.

  Crosby IK, Killen DA, Shaikh AN, McAllister BD, Reed WA. Crosby IK, et al. Am J Surg. 1974 Dec;128(6):746-51. doi: 10.1016/0002-9610(74)90063-4. Am J Surg. 1974. PMID: 4279562 No abstract available.
• Propranolol therapy in patients undergoing myocardial revascularization.

  Jones EL, Kaplan JA, Dorney ER, King SB 3rd, Douglas JS Jr, Hatcher CR Jr. Jones EL, et al. Am J Cardiol. 1976 Nov 23;38(6):696-700. doi: 10.1016/0002-9149(76)90345-3. Am J Cardiol. 1976. PMID: 998507
• Variant angina pectoris. Pain and arrhythmias controlled after postoperative myocardial infarction.

  Marsh CA, Benchimol A, Desser KB. Marsh CA, et al. JAMA. 1976 Feb 23;235(8):833-7. doi: 10.1001/jama.235.8.833. JAMA. 1976. PMID: 946312
• Management of cardiac disease in the general surgical patient.

  Salem DN, Homans DC, Isner JM. Salem DN, et al. Curr Probl Cardiol. 1980 May;5(2):1-41. doi: 10.1016/0146-2806(80)90008-0. Curr Probl Cardiol. 1980. PMID: 6110512 Review. No abstract available.
• Coronary surgery as secondary prevention. Objectives and achievements of surgical myocardial revascularization.

  Borman JB, Shimon DV, Appelbaum A, Gotsman MS. Borman JB, et al. Adv Cardiol. 1982;31:60-72. doi: 10.1159/000407121. Adv Cardiol. 1982. PMID: 6817599 Review. No abstract available.